Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

FZD7 Plays a Critical Role in Triple Negative Breast Cancer Proliferation


ABSTRACT: Breast cancer is genetically and clinically heterogeneous. Triple negative cancer (TNBC) is a subtype of breast cancer usually associated with poor outcome and lack of benefit from target therapy. A pathway analysis in a microarray study was performed using TNBC compared with non-triple negative breast cancer (non-TNBC). Overexpression of several Wnt pathway genes, such as frizzled homolog 7 (FZD7), Low density lipoprotein receptor-related protein 6 (LRP6) and transcription factor 7 (TCF7) has been observed in TNBC. Focus was given to the Wnt pathway receptor, FZD7. To validate its function, inhibition of FZD7 using FZD7shRNA was carried out. Notably decreased cell proliferation, suppressed invasiveness and colony formation in triple negative MDA-MB-231 and BT-20 cells were observed. Mechanism study indicated that these effects occurred through silencing the canonical Wnt signaling pathway, as evidenced by loss of nuclear accumulation of ï?¢-catenin and decreased transcriptional activity of TCF7. In vivo study revealed that FZD7shRNA significantly suppressed the tumor formation in xenotransplation mice due to decrease cell proliferation. Our finding suggests that FZD7 involved canonical Wnt signaling pathway is essential for tumorigenesis of TNBC. Thus, FZD7 may be a biomarker and a potential therapeutic target for triple negative breast cancer. 14 pretreatment non-triple negative breast tumors compare with 5 triple negative breast tumor.

ORGANISM(S): Homo sapiens

SUBMITTER: Xiwei Wu 

PROVIDER: E-GEOD-27447 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

FZD7 has a critical role in cell proliferation in triple negative breast cancer.

Yang L L   Wu X X   Wang Y Y   Zhang K K   Wu J J   Yuan Y-C YC   Deng X X   Chen L L   Kim C C H CC   Lau S S   Somlo G G   Yen Y Y  

Oncogene 20110502 43


Breast cancer is genetically and clinically heterogeneous. Triple negative breast cancer (TNBC) is a subtype of breast cancer that is usually associated with poor outcome and lack of benefit from targeted therapy. We used microarray analysis to perform a pathway analysis of TNBC compared with non-triple negative breast cancer (non-TNBC). Overexpression of several Wnt pathway genes, such as frizzled homolog 7 (FZD7), low density lipoprotein receptor-related protein 6 and transcription factor 7 (T  ...[more]

Similar Datasets

2011-06-01 | GSE27447 | GEO
2021-03-05 | PXD021181 | Pride
2022-02-27 | GSE197213 | GEO
2022-02-22 | GSE197000 | GEO
2022-04-29 | GSE201526 | GEO
2015-09-24 | E-GEOD-69106 | biostudies-arrayexpress
2015-01-24 | E-GEOD-65238 | biostudies-arrayexpress
2024-12-08 | PXD047648 | JPOST Repository
2014-06-11 | E-GEOD-58135 | biostudies-arrayexpress
2021-06-24 | PXD025238 | Pride